Study to Design a Precision Nutrition Strategy At a Group Level in the Elderly
NUTRIMET
Study to Design a Tailored Precision Nutrition Strategy Based on Metabotypes in the Elderly
1 other identifier
interventional
127
1 country
1
Brief Summary
From a public health point of view, personalized nutritional recommendations, at the individual level, are difficult to achieve in the short-medium term, especially in population segments with less purchasing power. Therefore, a more realistic vision in the short term and with a more favourable cost/effectiveness ratio consists of carrying out dietary advice at the group level through the identification of metabotypes, which can be defined as groups of individuals with similar metabolic profiles. The application of tailored precision nutrition aimed at the elderly is detected as a strategy to understand the different alterations associated to aging and to design innovative nutritional interventions that address this physiological process, favouring a healthy ageing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 5, 2022
CompletedFirst Submitted
Initial submission to the registry
September 29, 2022
CompletedFirst Posted
Study publicly available on registry
October 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 3, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 3, 2023
CompletedMarch 12, 2025
March 1, 2025
12 months
September 29, 2022
March 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Concordance between the nutritional recommendations generated at the group level and at the individual level
To assess the concordance between the two methods used (group vs individual nutritional recommendations) the following will be considered: * How many of the nutrients identified as main objectives match between the 2 methods (in percentage) * How many nutritional recommendations generated by the 2 methods agree with each other (in percentage)
At the final point (month 14)
Study Arms (1)
Tailored nutritional recommendations for each metabotype
OTHERVolunteers that will be clustered into metabotypes and will recieve tailored nutritional recommendations according to their metabotype.
Interventions
Tailored nutritional recommendations for each metabotype detected (at the group level), that will be delivered through a mobile application. Moreover, each volunteer will recieve individualized nutritional recommendations.
Eligibility Criteria
You may qualify if:
- Men and women over 65 years of age
- Have or have access (caregiver, family member) to a smartphone or tablet with Android operating system version 6 (API 23) or higher, with internet access
- Have the signed informed consent before the initial screening visit
You may not qualify if:
- Have food allergies or intolerances
- Have diarrhea
- People with irritable bowel syndrome or inflammatory bowel disease.
- Present some severe chronic pathology with clinical manifestations such as cardiovascular disease, coronary disease, chronic kidney disease or cancer.
- Following a prescribed diet for any reason, including weight loss, in the past month.
- Recent use of antibiotics in the last two weeks.
- Consumption of prebiotics and/or probiotics in the 30 days prior to the study
- Have a BMI \<18.5 kg/m2
- Smoke more than 10 cigarettes a day
- Consume more than 14 standard drinking units (SDUs) of alcoholic beverages per week
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fundació Eurecatlead
- Consorci Sanitari del Maresme (CsdM)collaborator
- Centro de investigación biomédica en red enfermedades hepáticas y digestivas (Ciberhd)collaborator
- Bana Hostingcollaborator
- Sixtemiacollaborator
Study Sites (1)
Consorci Sanitari del Maresme
Mataró, Spain
Study Officials
- PRINCIPAL INVESTIGATOR
Pere Clavé, MD, PhD
Consorci Sanitari del Maresme (CsdM)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2022
First Posted
October 5, 2022
Study Start
September 5, 2022
Primary Completion
September 3, 2023
Study Completion
September 3, 2023
Last Updated
March 12, 2025
Record last verified: 2025-03